Incyte Plays Down Ruxolitinib Cream Label Worries Following Atopic Dermatitis Approval

Opzelura Is First Topical JAK Inhibitor Approved In US

 
• By Sten Stovall
Ruxolitinib Cream Approved With JAK-Class Boxed Warnings • Source: Alamy

More from New Products

More from Scrip